Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

3 Small-Cap ETFs to Watch as Russell 2000 Hits Record

BY | ETF Database
12:58 pm ET 08/17/26 | 18 VIEWS
The Russell 2000 closed at a new record high Friday amid continued upwards momentum for several market indexes. That index, with its focus on small-caps, could prove an intriguing source of investing opportunities, given the right approach. These three small-cap ETFs offer useful tools to invest in the space amid success for the noted small cap index.Key Takeaways: The Russell 2000 set a record Friday, hitting 3,068.54. That record speaks to the broader appeal for small-caps, offering value and diversification opportunities away from concentration risk. Small-cap ETFs offer strong options to meet those goals and offer robust performance, as well. While it dropped Monday, the Russell 2000 has still produced healthy numbers over multiple time frames. The index has returned 21.83% YTD and 15.46% over the last six months. Small-caps have picked up some interest amid significant, top-heavy concentration risk in the market. Which small-cap ETFs, then, might be worth considering in that landscape? Small-cap ETFs include a variety of styles and approaches that can fit different portfolios. Take, for example, the ALPS Medical Breakthroughs ETF (SBIO B-).Small-Cap ETFs to Watch as Russell Sets RecordSBIO charges 50 basis points (bps) to track the S-Network Medical Breakthroughs Index. Falling into ETF Database’s small-caps asset class, the index includes biotech names with one or more drugs in Phase II or III FDA trials. That focus on rising names and innovators in biotech has helped the ETF return 30.65% YTD. Next, there are ETFs like the VictoryShares Small Cap Free Cash Flow ETF (SFLO ). SFLO charges a 49-bps fee to track its own index of 200 small-caps perceived to have strong free cash flows and high growth metrics. The index’s operators look for firms in 120% of the capitalization of the biggest name in the Russell 2000. Together with that cash flow focus, SFLO has returned 34.7% YTD. The small-caps ETF will see its notable three-year ETF milestone this December. See more: AI Infrastructure Firm Nebius Spikes: Get Exposure in THNQ Finally, the iShares U.S. Small Cap Value Factor ETF (SVAL B+) can intrigue. SVAL charges a 20-bps fee to track the equally-weighted Russell 2000 Focused Value Select Index. The fund’s index targets 250 small-caps meeting value standards, screening the Russell 2000 for liquidity, leverage, and volatility. Excluding 20% of the least liquid and most leveraged and volatile stocks, the fund has returned 29.2% YTD. Overall, then, that trio of small-cap ETFs can not only help diversify a portfolio, but also provide strong sources of performance. Whether via screening for free cash or liquidity, or even looking into particular categories of smaller firms, small-cap ETFs have a role to play as the category sets records. For more news, information, and analysis, visit the Thematic Investing Content Hub. VettaFi LLC (“VettaFi”) is the index provider for SFLO and SBIO for which it receives an index licensing fee. However, SFLO and SBIO are not issued, sponsored, endorsed, or sold by VettaFi, and VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of SFLO and SBIO.

More Commentary

The Hidden Strength of Active Sector ETFs Spiking Right Now
BY | ETF Database
6:41 am ET 08/17/26 | 29 VIEWS
AI Infrastructure Trade Still Alive. Seize It with SOXL
BY | ETF Database
7:10 am ET 08/17/26 | 36 VIEWS
Thematic ETFs Dominated Last Weeks Top Stories
BY | ETF Database
12:25 pm ET 08/17/26 | 14 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.